Matching slides 10,471
Current window 6,091-6,120
Pages 350
Rows per page 30
Slide type: Tractionclear collectionreset all

Slide type

6,091-6,120 of 10,471

filter-aware
14
The slide uses a trend line overlay to emphasize growth trajectory.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
06
Includes a map of the US highlighting Nevada and a list of key company stats.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations Beat · Problem1 hit
23
The charts show a shift in revenue mix from DTC-heavy to a more balanced OEM/DTC split over time.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations Beat · Financials1 hit
06
Includes specific financial breakdown of deal value and R&D funding obligations.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
20
Includes before/after clinical photos and a comparative table against Mogamulizumab.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
21
Equillium | Investor Presentation Deck | 39 slidesEquillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
13
The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate proof of concept.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needs1 hit
14
Includes two waterfall plots comparing patient responses; source cited as Novartis materials.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Challenges in current cancer treatment and unmet needs1 hit
16
Waterfall plot shows individual patient responses; table compares efficacy metrics against Dacarbazine and Binimetinib.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical dataLoop · Cost Of Inaction1 hit
18
The slide uses a swimmer plot to visualize individual patient treatment duration and response status.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical dataLoop · Cost Of Inaction1 hit
19
The slide uses a summary calculation (13/39 = 33.3% ORR) to aggregate results across two different clinical phases.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical dataLoop · Cost Of Inaction1 hit
20
Swimmer plot showing individual patient treatment duration and response status (NE, PD, PR, SD).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical dataLoop · Cost Of Inaction1 hit
21
The diagram uses a flow-chart structure to categorize patient outcomes (off treatment vs on treatment) and further breaks down the 'on treatment' group into SDs and PRs with specific progression delay metrics.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
22
The chart displays adverse events occurring in >=10% of patients (n=15).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
28
The slide compares tumor volume reduction across two different CDX models (WiDr and RKO) using various treatment regimens.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
29
Includes waterfall plot and swimmer plot for clinical trial results.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
31
The slide uses a process-oriented flow to demonstrate clinical validation milestones.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
33
Data presented as tumor volume over time (days) with error bars representing SEM.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
40
The slide displays four distinct survival plots (HK301, GS025, HK336, GS187) showing statistically significant survival improvements (***) with ERAS-801 treatment.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
41
The slide uses a waterfall plot to show individual model responses and pie charts to summarize efficacy across the total cohort vs. the specific EGFR-mutant/amplified subset.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations Beat · Erasca's pipeline and clinical data1 hit
50
The chart displays individual patient responses to treatment, with bars colored by dosage level.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
51
The chart displays individual patient treatment timelines, with markers for partial response, stable disease, and progressive disease.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
06
Includes seller census data points and growth metric.Etsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a combination of bar charts and trend indicators to demonstrate operational efficiency and growth.Etsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations 1 hit
10
Etsy | Investor Presentation Deck | 26 slidesEtsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations 1 hit
12
Uses a cumulative additive model to explain growth drivers.Etsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations 1 hit
13
Includes specific footnotes regarding currency neutrality and divestiture impacts.Etsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations 1 hit
14
Includes a waterfall chart for revenue and a bar chart with overlay for EBITDA.Etsy | Investor Presentation Deck | 26 slides · Etsy
Pitch deck Investor relations 1 hit
04
The slide uses a 3x2 grid layout to present key performance indicators.Exscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
05
Exscientia | Investor Presentation Deck | 76 slidesExscientia | Investor Presentation Deck | 76 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit